| ASSET | MONTH | % RETURN |
|---|---|---|
Kodiak Sciences (KOD) | September 2026 | 156.15% |
Iovance Biotherapeutics (IOVA) | September 2026 | 84.79% |
GRAIL, LLC (GRAL) | September 2026 | 77.37% |
MaxLinear (MXL) | September 2026 | 54.46% |
Cohu (COHU) | September 2026 | 51.59% |
FormFactor (FORM) | September 2026 | 50.41% |
10X Genomics (TXG) | September 2026 | 46.24% |
Solaris Energy Infrastructure (SEI) | September 2026 | 44.08% |
Twist Bioscience (TWST) | September 2026 | 43.2% |
AXT (AXTI) | September 2026 | 33.4% |
Cosan SA ADR (CSAN) | September 2026 | 32.89% |
CareDx (CDNA) | September 2026 | 30.18% |
Abcellera Biologics (ABCL) | September 2026 | 29.8% |
ChipMOS Technologies (IMOS) | September 2026 | 28.16% |
Aehr Test Systems (AEHR) | September 2026 | 27.88% |
Signet Jewelers (SIG) | September 2026 | 26.52% |
Precigen (PGEN) | September 2026 | 25.7% |
Strive (ASST) | September 2026 | 25.36% |
Rogers (ROG) | September 2026 | 23.93% |
Torm PLC Class A (TRMD) | September 2026 | 23.67% |
Recursion Pharmaceuticals (RXRX) | September 2026 | 23.65% |
Hafnia (HAFN) | September 2026 | 22.99% |
Veradermics (MANE) | September 2026 | 22.96% |
Ultra Clean (UCTT) | September 2026 | 21.38% |
VEON (VEON) | September 2026 | 20.86% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.